Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com

Newsfile March 9, 2020

LexaGene's LX Analyzer Successfully Detects Coronavirus RNA using the CDC's Tests

GlobeNewswire February 20, 2020

LexaGene's Analyzer is Designed to Detect Pathogens such as the Novel Coronavirus to Help Avert a Pandemic

GlobeNewswire January 27, 2020

Newly-developed Tests Achieve 100% Concordance on Superbug Strains from the CDC

GlobeNewswire January 21, 2020

LexaGene Provides Corporate Update

GlobeNewswire November 13, 2019

LexaGene Announces Closing of CAD$6.64 Million Financing

GlobeNewswire October 29, 2019

LexaGene Holdings Announces Filing of Final Prospectus

Canada NewsWire October 22, 2019

LexaGene Holdings Announces Pricing of Prospectus Offering

GlobeNewswire October 2, 2019

LexaGene Holdings Announces Proposed Offering of Units and Filing of Preliminary Prospectus

GlobeNewswire September 25, 2019

LexaGene Reports on Successful Results from Beta Testing in Human Clinical Diagnostics Laboratory

GlobeNewswire September 19, 2019

LexaGene Announces its Second Hemp-Cannabis Reference Testing Laboratory as a Beta Test Site

GlobeNewswire September 12, 2019

LexaGene Reports on Beta Results from Cannabis-Focused Testing Laboratory

GlobeNewswire September 5, 2019

LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory

GlobeNewswire August 8, 2019

LexaGene Approved by CDC and FDA Antibiotic Resistance Isolate Bank to Receive Samples to Test for Superbugs

GlobeNewswire July 30, 2019

LexaGene Files Three Additional US Patents Covering Technology

GlobeNewswire July 17, 2019

LexaGene's Beta Prototype Exceeds Expectations During Testing at Massachusetts Veterinary Referral Hospital

GlobeNewswire July 10, 2019

LexaGene Will Host a Free Webinar Providing an Overview of the Company

GlobeNewswire June 6, 2019

LexaGene Places its First Beta Prototype into Massachusetts Veterinary Referral Hospital

GlobeNewswire June 5, 2019

LexaGene Completes Development of Antibiotic Resistance Panel

GlobeNewswire May 15, 2019

LexaGene's Technology Successfully Detects a Common Fungus That Damages Agricultural Crops

GlobeNewswire April 30, 2019